Psience Quest

Quote:On the homepage of the health technology company Akili Interactive, there sits an intriguing line of copy: “Time to Play Your Medicine.”

That tagline serves as something of a futuristic mission statement for the Boston-based company, which focuses on bringing brain-training video games to market and is seeking to produce the first FDA-approved game treatment for attention deficit hyperactivity disorder, or ADHD. If it succeeds, it will be the first alternative to stimulant medication approved for the disorder—they’re calling it “digital treatment.”

Backed by rigorous research, the game, called Project: Evo, now in Phase III clinical trials—and Akili as a whole—were born out of Neuroscape, a neuroscience research lab led by Adam Gazzaley at the University of California, San Francisco.